Uterine Cancer - Adding Herceptin to Advanced and Metastatic Disease
Endometrial Cancer – Adding Herceptin to the Standard Protocol Prolongs Patients’ Lives
Background - Endometrial cancer and this trial Uterine-serous-carcinoma, USC, is an aggressive variant of endometrial cancer. This phase II trial evaluated Carboplatin+Taxol versus Herceptin +Carboplatin+Taxol in patients with advanced or…